Electronegative LDL induces MMP-9 and TIMP-1 release in monocytes through CD14 activation: Inhibitory effect of glycosaminoglycan sulodexide

• Published in: Biochimica et biophysica acta. Molecular basis of disease 2018-12, Vol.1864 (12), p.3559-3567
• Main Authors: Ligi, Daniela, Benitez, Sonia, Croce, Lidia, Rivas-Urbina, Andrea, Puig, Núria, Ordóñez-Llanos, Jordi, Mannello, Ferdinando, Sanchez-Quesada, Jose Luis
• Format: Article
• Language: English
• Subjects: Atherosclerosis; Electronegative LDL; Glycosaminoglycan; Matrix metalloproteinase; Sulodexide; Tissue inhibitor of metalloproteinase
• ISSN: 0925-4439; 1879-260X
• DOI: 10.1016/j.bbadis.2018.09.022

Electronegative LDL (LDL(−)) is involved in atherosclerosis through the activation of the TLR4/CD14 inflammatory pathway in monocytes. Matrix metalloproteinases (MMP) and their inhibitors (tissue inhibitors of metalloproteinase [TIMP]) are also crucially involved in atherosclerosis, but their modulation by LDL(−) has never been investigated. The aim of this study was to examine the ability of LDL(−) to release MMPs and TIMPs in human monocytes and to determine whether sulodexide (SDX), a glycosaminoglycan-based drug, was able to affect their secretion. Native LDL (LDL(+)) and LDL(−) separated by anion-exchange chromatography were added to THP1-CD14 monocytes in the presence or absence of SDX for 24 h. A panel of 9 MMPs and 4 TIMPs was analyzed in cell supernatants with multiplex immunoassays. The gelatinolytic activity of MMP-9 was assessed by gelatin zymography. LDL(−) stimulated the release of MMP-9 (13-fold) and TIMP-1 (4-fold) in THP1-CD14 monocytes, as well as the gelatinolytic activity of MMP-9. Co-incubation of monocytes with LDL(−) and SDX for 24 h significantly reduced both the release of MMP-9 and TIMP-1 and gelatinase activity. In THP1 cells not expressing CD14, no effect of LDL(−) on MMP-9 or TIMP-1 release was observed. The uptake of DiI-labeled LDL(−) was higher than that of DiI-LDL(+) in THP1-CD14 but not in THP1 cells. This increase was inhibited by SDX. Experiments in microtiter wells coated with SDX demonstrated a specific interaction of LDL(−) with SDX. LDL(−) induced the release of MMP-9 and TIMP-1 in monocytes through CD14. SDX affects the ability of LDL(−) to promote TIMP-1 and MMP-9 release by its interaction with LDL(−). [Display omitted] •LDL(−) stimulates the release of MMP-9 and TIMP-1 in THP1-CD14 human monocytes.•LDL(−) increases the gelatinolytic activity of MMP-9 in THP1-CD14 cells.•Sulodexide prevents the MMP release and activity in THP1-CD14 cells induced by LDL(−).•CD14 plays a key role in triggering the signaling pathway leading to MMP-9 release.